SEC Form 4 · accession 0001600132-17-000034
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Megan Schoeps
Officer — Principal Financial Officer
Period of report
Mar 16, 2017
Accepted (ET)
Mar 20, 2017 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 16, 2017 | A | 24,039 | $0.00 | A | 28,707 | D |
Table II — derivative securities
No Table II lines on this filing.